Browse > Article

Efficacious Pleurodesis with OK-432 Plus Autoblood or OK-432 Against the Pneumothorax with Persistent Air Leak  

Kim, Hyoung Soo (Department of Thoracic & Cardiovascular Surgery, College of Medicine, Hallym University)
Choi, Goang Min (Department of Thoracic & Cardiovascular Surgery, College of Medicine, Hallym University)
Publication Information
Tuberculosis and Respiratory Diseases / v.60, no.1, 2006 , pp. 72-75 More about this Journal
Abstract
Background : This report reviews our experience with persistent air leaks in the peumothorax that were not considered candidates for surgical treatment in order to evaluate the efficacy and risks of the OK-432 plus autoblood or OK-432 pleurodesis. Material & Methods : From March 2004 to July 2005, 8 consecutive patients who had an air leak in the pneumothorax over 5 days and had been treated with OK-432 plus autoblood or OK-432 pleurodesis. The patients were not considered candidates for surgical treatments because the chest CT findings revealed severe chronic lung disease with multiple bullae and/or bullous changes. A prolonged air leak with/without dead space was treated with either OK-432 plus autoblood or OK-432 pleurodesis. The efficacy and side effects of OK-432 pleurodesis were assessed by determining the duration of the air leak, the number of pleurodesis, the patients' symptoms, measurements of the white blood cell count and the c-reactive protein level. Results : All of eight patients were male and the mean age was $72.4{\pm}8.5$. The mean number of pleurodesis was $1.9{\pm}1.1$ and the mean duration of the air leak was $4.6{\pm}4.6days$ after pleurodesis. Side effects after pleurodesis were encountered in 7 patients, which included a chilling sensation in 7 cases, chest pain in 5 cases, headache in 3 cases, local heat sensation in 2 cases, and fever in 1 case. Leukocytosis was observed in 6 patients, and the mean of WBC count and CRP were $14500{\pm}2100$ and $21.9{\pm}11.4mg/dL$, respectively. Conclusion : Either OK-432 plus autoblood or OK-432 pleurodesis has acceptable side effects, and can be considered a treatment option for persistent air leaks in the pneumothorax that are not candidates for surgical treatment.
Keywords
Pneumothorax; Pleurodesis; OK-432;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Weissberg D, Ben-Zeev I. Talc pleurodesis: experience with 360 patients. J Thorac Cardiovasc Surg 1993;106:689-95
2 Lang-Lazdunski L, Coonar AS. A prospective study of autologous 'blood patch' pleurodesis for persistent air leak after pulmonary resection. Eur J Cardiothorac Surg 2004;26:897-900   DOI   ScienceOn
3 Yoon SM, Shin SJ, Kim YC, Shon JW, Yang SC, Yoon HJ, et al. The effects of autologous blood pleurodesis in the pneumothorax with persistent air leak. Tuberc Respir Dis 2000;49:724-32   DOI
4 Chung JH, Park MS, Cheong JH, Kim YS, Chang J, Kim JH, et al. Comparison of OK-432 and doxycycline pleurodesis for malignant pleural effusions caused by lung cancer. Tuberc Respir Dis 2002;52:590-6   DOI
5 Yokomise H, Satoh K, Ohno N, Tamura K. Autoblood plus OK 432 pleurodesis with open drainage for persistent air leak after lobectomy. Ann Thorac Surg 1998;65:563-5   DOI   ScienceOn
6 Kim KU, Cha KY, Han SH, Yun YI, Park SW, Kim DJ, et al. A case of acute respiratory distress syndrome after talc pleurodesis. Tuberc Respir Dis 2001;51:265-9   DOI
7 Kim MH, Lee SH, Lee HJ, Kim KT, Lee IS, Kim HM. A case of idiopathic bilateral chylothorax treated by chemical pleurodesis with OK 432. Korean J Thorac Cardiovasc Surg 1995;28:951-3
8 Song JP, Lee JH, Kim BY, Kang KM. Pleurodesis with autologous blood plus sclerosing agents. Korean J Thorac Cardiovasc Surg 1999;32:92-5
9 Kimura I, Ohnishi T, Yasuhara S, Sugiyama M, Urabe Y. Immunochemotherapy in human lung cancer using the streptococcal agent OK-432. Cancer 1976;37:2201-3   DOI   ScienceOn
10 Kishi K, Homma S, Sakamoto S, Kawabata M, Tsuboi E, Nakata K, et al. Efficious pleurodesis with OK-432 and doxorubicin against malignat pleural effusion. Eur Respir J 2004;24:263-6   DOI   ScienceOn